Clinical Trials Logo

Granulosa Cells clinical trials

View clinical trials related to Granulosa Cells.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT05558046 Not yet recruiting - DNA Damage Clinical Trials

Predictive Value of Granulosa Cell DNA Damage in the Success of Assisted Reproductive Technique

Start date: October 1, 2022
Phase:
Study type: Observational

Deoxyribonucleic acid (DNA) damage of granulosa cells obtained during oocyte retrieval will be evaluated by flow cytometry with detection of Histone H2A.X and Phosphorylated Gamma H2A.X protein levels in patients with low ovarian reserve and unexplained infertile patients as a control group undergoing intracytoplasmic sperm injection (ICSI) treatment. Fertilization, embryo quality, transfer rate, implantation, clinical pregnancy will be recorded as well as demographic data. DNA damage of granulosa cells will be compared between two groups. The effect of DNA damage of granulosa cells on fertilization, quality of oocyte and embryo, implantation, and clinical pregnancy will be also evaluated.